Regulus Therapeutics (RGLS) Enters $100M Oversubscribed Private Placement

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Regulus Therapeutics (RGLS) Enters $100M Oversubscribed Private Placement

Regulus Therapeutics Announces Oversubscribed $100 Million Private Placement of Equity

March 12, 2024 6:32 AM EDT

SAN DIEGO, March 12, 2024 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that it has entered into a definitive securities purchase agreement in connection with a private placement to certain institutional investors and other accredited investors. The oversubscribed financing includes participation from new and... More